FDA Inspection 1319444 — Agilent Technologies Inc
The FDA completed an inspection of Agilent Technologies Inc on May 6, 2026 in Boulder, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 6, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boulder, CO (United States)